Correction to press release regarding in change in number of shares and votes in Ascelia Pharma AB
In the press release published yesterday, the number of C shares issued during March was stated to be 507,752. The correct number should have been 510,545 (i.e. a difference of 2,793 shares). Consequently, as of 31 March 2020, the number of shares in Ascelia Pharma AB amounts to 23,999,453 shares, of which 23,488,908 are ordinary shares with one vote per share and 510,545 are series C shares with one-tenth of a vote per share. The number of votes in the company amounts to 23,539,962.5 votes. For more information, please contact: Magnus Corfitzen, CEOEmail: moc@ascelia.com